Incyte Corp to Discuss Highlights from Oral PD-L1 Program from SITC Transcript
Hello, and welcome to the Incyte Data Highlights from SITC Teleconference and Webcast. (Operator Instructions)
It's now my pleasure to turn the call over to Christine Chiou, Head of Investor Relations. Please go ahead.
Thank you, Kevin. Good evening, and welcome to Incyte's Oral PD-L1 Program Highlights Conference Call and Webcast at SITC. The slides presented today are available for download on the Investors section of our website. Joining me on the call today are Herve and Steven, who will deliver our prepared remarks; and Jeff Jackson, our Vice President of Translational Sciences, who will join us for the Q&A.
Before we begin, I'd like to remind you that some of the statements made during the call today are forward-looking statements and are subject to a number of risks and uncertainties that may cause our actual results to differ materially, including those described in our 10-Q for the period ended September 30, 2021, and from time to time in our other SEC documents.
We will
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |